Related Experiment Video
Updated: Feb 17, 2026
04:41
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
19.5K
Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug
Max Lam1, Joey W Trampush2, Jin Yu3
1Institute of Mental Health, Singapore, Singapore.
Cell Reports
|November 30, 2017
Summary
This large genome-wide study identified 70 genetic loci linked to general cognitive ability. Findings reveal connections between cognitive function, brain gene expression, and various health conditions.
Area of Science:
- Genetics
- Neuroscience
- Psychiatry
Background:
- General cognitive ability (g) is a key human trait with significant heritability.
- Understanding the genetic architecture of cognitive ability is crucial for addressing related neurological and psychiatric conditions.
Purpose of the Study:
- To identify genomic loci associated with general cognitive ability.
- To explore biological pathways and gene expression patterns linked to cognitive ability.
- To investigate genetic correlations between cognitive ability and other phenotypes.
Main Methods:
- Performed a large-scale genome-wide association study (GWAS) on general cognitive ability (n=107,207).
- Integrated GWAS results with educational attainment data.
- Utilized competitive pathway analysis, transcriptome-wide, and epigenome-wide analyses.
Main Results:
- Identified 70 independent genomic loci associated with general cognitive ability.
- Found significant enrichment for genes involved in Mendelian disorders with intellectual disability.
- Implicated neurogenesis, synaptic regulation, and specific drug targets (cinnarizine, LY97241).
- Discovered enrichment of implicated loci in genes expressed across brain regions, particularly in neurons.
- Reported genetic correlations with psychiatric and autoimmune disorders, longevity, and maternal age at first birth.
Conclusions:
- The study provides novel insights into the genetic underpinnings of general cognitive ability.
- Findings highlight the role of specific biological pathways and neuronal gene expression.
- Genetic correlations suggest pleiotropic effects of cognitive ability genes across diverse phenotypes.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
671
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
671
01:26Neurochemical Transmission: Sites of Drug Action
3.7K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.7K
01:29Pharmacogenomics: Identification of New Drug Targets
10
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
10
01:11Genome-wide Association Studies-GWAS
15.8K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.8K